Skip to main content

Table 2 Sedation choices by continent before the COVID-19 pandemic

From: Practices in sedation, analgesia, mobilization, delirium, and sleep deprivation in adult intensive care units (SAMDS-ICU): an international survey before and during the COVID-19 pandemic

Variables

n

Asia

169 (%)

Europe

408 (%)

South America

739 (%)

Drugs usually used for sedation

 Midazolama

65.1

80.9

92.3

 Lorazepama

10.1

4.4

16.6

 Haloperidolb

20.7

20.3

28.3

 Morphinea

45.6

17.2

17.6

 Fentanyla

77.5

19.1

53.6

 Propofola

50.9

91.9

78.1

 Remifentanila

0.6

27.9

6.1

 Dexmedetomidinea

64.5

61.00

67.9

 Ketaminea

5.9

25.7

34.2

 Quetiapinea

14.2

8.3

29.2

Sedative drugs used for sedation in patients with septic shock

 Midazolama

34.9

64.6

69.1

 Lorazepam

3

0.7

2.7

 Haloperidolb

4.1

0.7

3.9

 Morphinea

32.5

11.8

7

 Fentanyla

79.9

25

66.1

 Propofola

6.5

46.6

44.7

 Remifentanila

0.59

20.3

10.2

 Dexmedetomidinea

20.1

12

30.9

 Ketaminea

8.3

16.2

32

 Quetiapineb

2.4

0.3

4.2

Sedative drugs used for sedation in patients with ARDS

 Midazolama

49.7

66.7

80.4

 Lorazepamb

0.6

0.3

4

 Haloperidol

2.4

1

3

 Morphinea

39

14.5

10

 Fentanyla

82.3

29.9

73

 Propofola

22.5

67.2

65.6

 Remifentanila

0

21.6

10.26

 Dexmedetomidinea

35.5

11.8

26.1

 Ketaminea

2.4

16.4

30.9

 Quetiapine

3.6

0.5

3.9

Sedative drugs used for sedation in agitated patients under noninvasive ventilation

 Midazolamb

20.1

13.7

8.9

 Lorazepam

5.3

5.9

8.1

 Haloperidolb

23.7

35.3

34

 Morphineb

13.6

14.5

23.7

 Fentanyla

32

6.1

14.9

 Propofola

3

25.5

10.8

 Remifentanila

1.8

9.6

3.7

 Dexmedetomidinea

38.5

55.9

75.5

 Ketaminea

0.6

7.4

16.6

 Quetiapinea

13

10.3

31.7

  1. a p < 0.001; bp < 0.05; cARDS, acute respiratory distress syndrome
  2. Italic emphasis are the most frequent choice in each context